Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8226241 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
Our findings suggest that men with HIV treated with EBRT have a similar risk of BF; however, high viral loads may contribute to an increased risk. This analysis supports that HIV-positive men with prostate cancer can be treated with definitive EBRT with similar disease control and toxicity outcomes as in the general population.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Shannon M.D., Ashesh M.D., Scott M.D., Peter M.D., Karen M.D., Jerome M.D., Cynthia M.D.,